RNA Interference: Application to Drug Discovery and Challenges to Pharmaceutical DevelopmentISBN: 978-0-471-77151-7
Hardcover
332 pages
February 2011
|
PAUL H. JOHNSON, PhD, is a cofounder and Chief Scientific Officer at PhaseRx, Inc. He is the author of numerous scientific papers and patents, and was the recipient of the 2007 Jeffrey Wenig Memorial Award for Outstanding Achievement in Drug Delivery.